Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Jeong-Im Sin"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 7, Pp 1910-1922 (2021)
Anti-programmed death ligand 1 (PD-L1) therapy has been beneficial in treating patients with certain cancers. Here, we tested whether anti-PD-L1 therapy is effective for controlling different types of tumors using animal models of TC-1, MC38 and B16.
Externí odkaz:
https://doaj.org/article/aeb7f2529a6e4481abeef1bf69bdac5a
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Legionella pneumophila, an intracellular bacterium, may cause life-threatening pneumonia in immunocompromised individuals. Mononuclear cells and antibodies have been reported to be associated with the host defense response against L. pneumophila. Thi
Externí odkaz:
https://doaj.org/article/4fbc716b9e8445aa90db71916f1ffafc
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83765 (2013)
Human papillomavirus (HPV) infection is a major cause of cervical cancer. Here, we investigate whether concurrent therapy using HPV E7 DNA vaccines (pE7) plus IL-2 vs. IL-15 cDNA and anti-4-1BB Abs might augment antitumor activity against established
Externí odkaz:
https://doaj.org/article/da4c525fbc874caa8e70086875630d5b
Publikováno v:
Hum Vaccin Immunother
Anti-programmed death ligand 1 (PD-L1) therapy has been beneficial in treating patients with certain cancers. Here, we tested whether anti-PD-L1 therapy is effective for controlling different types of tumors using animal models of TC-1, MC38 and B16.
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Scientific Reports
Scientific Reports
Tumor cells tend to behave differently in response to immune selective conditions. Contrary to those in therapeutic antitumor conditions, tumor cells in prophylactic antitumor conditions lose antigen expression for antitumor immune escape. Here, usin
Publikováno v:
DNA and Cell Biology. 37:850-860
The role of chemotherapeutic agents in tumor immunotherapy is still controversial. In this study, we test using a TC-1 tumor model whether gemcitabine plus E7 peptide vaccine regimens (E7 peptides+CpG-ODN+anti-4-1BB Abs) may result in tumor cure in m
Publikováno v:
Cellular immunology. 367
Melanomas exhibit the highest rate of heterogeneity among cancer cell types. In this study, we tested the two types of B16 melanoma cells (B16-S0-1 and B16-S1-1) showing resistance to antitumor immunity. These cells expressed Trp2 protein. Contrary t
Publikováno v:
Frontiers in Immunology
Legionella pneumophila, an intracellular bacterium, may cause life-threatening pneumonia in immunocompromised individuals. Mononuclear cells and antibodies have been reported to be associated with the host defense response against L. pneumophila. Thi
Publikováno v:
DNA and Cell Biology. 36:801-811
Therapeutic control of tumors is challenging as they tend to alter their biological functions and microenvironment. In a CT26/HER2 tumor model, HER2 DNA vaccines and even anti-PD-L1 Abs failed to display antitumor therapeutic activity while inducing
Publikováno v:
Clinical and Experimental Vaccine Research
PURPOSE The goal of this study was to investigate the utility of DNA vaccines encoding Ebola virus glycoprotein (GP) as a vaccine type for the production of GP-specific hybridomas and antibodies. MATERIALS AND METHODS DNA vaccines were constructed to